Stop Guessing About Your Health. Your Genes Have Answers.

Your MTHFR gene encodes an enzyme that performs one of the most critical chemical reactions in your body: converting dietary B vitamins into their active, usable forms. This process is called methylation. When methylation works properly, B vitamins get converted into cofactors that power ATP production (the chemical energy your cells run on), synthesize neurotransmitters, and repair DNA. It’s foundational to everything.

Approximately 40% of people with European ancestry carry the MTHFR C677T variant, which reduces enzyme efficiency by 40 to 70%. This doesn’t mean you have a disease. It means your cells are converting B vitamins at a fraction of the rate they should be. You can eat a diet rich in leafy greens and B vitamins and still be functionally depleted at the cellular level because your body simply cannot process them efficiently.

The experience is usually chronic: persistent low energy despite adequate sleep, difficulty concentrating, slow recovery from illness, and sometimes mood instability. If you have this variant, standard B vitamins (cyanocobalamin, folic acid) won’t help much because your body still has to convert them. You’re asking a broken enzyme to do its job harder.

You know vitamin D is important. But having enough vitamin D in your blood is only half the equation. Your cells also need to receive the signal that vitamin D is sending. That’s where VDR comes in. The VDR gene encodes the vitamin D receptor, a protein on the surface of your cells that binds vitamin D and allows it inside. Without a functioning receptor, vitamin D just floats in your blood doing very little.

Roughly 30 to 50% of the population carries a VDR variant that reduces cellular uptake of vitamin D. This means your cells are less responsive to vitamin D signaling, even when your blood levels look normal. Vitamin D is critical for mitochondrial biogenesis (building new energy-producing structures in your cells), calcium absorption, immune regulation, and mood. When cellular uptake is impaired, all of these processes slow down.

You might take vitamin D supplements, have your blood levels checked, find them “normal,” and still feel persistent fatigue, brain fog, and low mood. This is the VDR story. Your body isn’t absorbing the problem. It’s that your cells can’t hear the signal vitamin D is sending.

COMT is a cleanup enzyme. It clears dopamine, norepinephrine, and epinephrine (adrenaline) from your nervous system once their job is done. When you encounter a stressor, your sympathetic nervous system activates and floods your brain with these neurochemicals. That’s normal and necessary. But then COMT should clear them so your nervous system can reset and you can sleep. If COMT works slowly, these chemicals linger.

Approximately 25% of the population is homozygous for the COMT Val158Met slow variant. Slow COMT means your nervous system stays activated long after the stressor has passed, burning through neurological reserves and keeping you wired when you should be resting. You might find yourself alert and agitated at night, unable to unwind, or waking in the early morning with racing thoughts. Your sympathetic nervous system is still on high alert.

The experience varies. Some people describe themselves as “wired but tired,” others struggle with anxiety that doesn’t respond well to standard treatments, and many experience non-restorative sleep even when they get eight hours. Caffeine is particularly problematic because it further elevates dopamine and norepinephrine, and slow COMT can’t clear it efficiently.

TCF7L2 is a transcription factor that regulates glucose metabolism and insulin secretion. It controls how efficiently your pancreas responds to blood glucose, how insulin-sensitive your cells are, and ultimately how much steady energy you maintain throughout the day. When TCF7L2 works properly, your blood sugar stays stable, insulin sensitivity remains high, and energy is consistent.

Roughly 35% of the population carries the TCF7L2 rs7903146 variant associated with reduced glucose regulation efficiency. This variant is linked to higher fasting glucose, lower insulin sensitivity, and a greater tendency toward blood sugar dysregulation, even in people who are lean and eat well. It’s not about diet quality alone. It’s about how your cells respond to insulin at a genetic level.

You might notice energy crashes in the afternoon, increased cravings for carbohydrates after meals, difficulty losing weight despite restriction, or persistent fatigue that improves briefly after eating and then crashes again. These aren’t character flaws or discipline failures. They’re the signature of inefficient glucose regulation. Your cells just don’t handle carbohydrates as efficiently as someone without this variant does.

SLC6A4 encodes the serotonin transporter, the protein that recycles serotonin back into neurons after it’s been released. Think of it as a recycling system: serotonin gets used to send signals between brain cells, then the transporter pulls it back so it can be used again. This recycling is how your brain maintains consistent serotonin levels. If recycling is impaired, serotonin gets depleted faster, and your baseline levels drop.

Approximately 40% of the population carries at least one copy of the SLC6A4 5-HTTLPR short allele, which impairs serotonin recycling. This reduced recycling means your brain has less serotonin available, which destabilizes mood, but more importantly for sleep, it disrupts melatonin production because serotonin is the precursor to melatonin. You might sleep eight hours and wake up feeling like you didn’t really sleep at all. Your sleep is non-restorative.

Serotonin also regulates circadian rhythm. When recycling is impaired, your internal clock becomes less stable. You might struggle with sleep onset, or wake frequently throughout the night, or experience early morning awakening that you can’t explain. Many people with this variant report that standard sleep advice (dark room, consistent schedule) helps somewhat, but they never feel truly rested.

APOE encodes apolipoprotein E, a protein that transports cholesterol and fats throughout your brain and body. It’s critical for brain cell maintenance, repair, and cognitive function. Your APOE genotype (determined by which variants you inherited: E2, E3, or E4) influences how well your brain handles inflammation, oxidative stress, and cholesterol management for decades to come.

Roughly 25% of the population carries at least one APOE4 allele. The APOE4 variant confers increased vulnerability to neuroinflammation and amyloid accumulation in the brain, raising cognitive risk in aging. This doesn’t mean you’ll develop Alzheimer’s disease. It means your brain is less efficient at clearing inflammatory proteins and managing lipid metabolism, so proactive intervention now matters significantly more.

You might not notice APOE effects in your 30s or 40s. But APOE shapes long-term risk across decades. If you carry the APOE4 variant, your brain benefits much more from specific interventions like cardiovascular fitness, cognitive engagement, anti-inflammatory diet, omega-3 supplementation, and metabolic health optimization than someone with APOE2 or APOE3. Knowing your APOE status now lets you prioritize the interventions that actually protect your brain long-term.